As J&J eyes approval for its one-shot COVID-19 vax, it sends off phase 3 data for a swift WHO listing

Johnson & Johnson has sent off its phase 3 data package to the World Health Organization (WHO) for its one-and-done COVID-19 vaccine shot just a few weeks after showing off its efficacy.

Specifically, J&J’s research arm Janssen has asked for an Emergency Use Listing (EUL) from the WHO, a procedure designed to speed up the use of new or unlicensed products during public health emergencies, such as COVID-19. It has already been used for several others, including the COVID-19 vaccine from AstraZeneca and the University of Oxford.